Liquid biopsies (also called serum testing) is a practice already approved in Europe for EGFR lung cancer patients. Drawing blood to test for acquired resistance is easier and quicker than needle biopsies. How long until it is standard practice in the US?

[powerpress]

Download Transcript

Please feel free to offer comments and raise questions in our Discussion Forums.